Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial. (Q31929933)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial. |
scientific article |
Statements
Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial (English)
Peters S
Götting B
Trümmel M
Rust H
1 February 2001